FDA expands warning on diet products.
Voelker
Rebecca
R
D019440:Anti-Obesity Agents / Q000009:adverse effects; D019587:Dietary Supplements / Q000009:adverse effects; D004348:Drug Labeling; D004366:Nonprescription Drugs / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D019440:Anti-Obesity Agents; D004366:Nonprescription Drugs